文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

新冠后神经状态下注意力表现测试的有效性

Validity of the test for attentional performance in neurological post-COVID condition.

作者信息

Seibert Susan, Eckert Irina, Widmann Catherine N, Ebrahimi Taraneh, Bösl Fabian, Franke Christiana, Prüss Harald, Schultze Joachim L, Petzold Gabor C, Shirvani Omid

机构信息

Center for Neurology, University of Bonn Medical Center, Bonn, Germany.

German Center for Neurodegenerative Diseases (DZNE), Venusberg-Campus 1, C99, 53127, Bonn, Germany.

出版信息

Sci Rep. 2025 Jul 7;15(1):24208. doi: 10.1038/s41598-025-09128-2.


DOI:10.1038/s41598-025-09128-2
PMID:40624269
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12234741/
Abstract

Neurological post-COVID condition (PCC) often involves attentional deficits that impact daily functioning. Traditional paper-based tests, like the Trail-Making Test (TMT), may inadequately capture these impairments due to their short duration and dependence on numerical and alphabetic sequencing. This study evaluates the validity of three subtests of the computerized Test for Attentional Performance (TAP) as alternatives for detecting attentional impairments in PCC. In the ongoing NEURO LC-19 DE study, 108 subjects aged 18 to 79 years, with PCC-related cognitive complaints (n = 67, 73% f) and healthy controls (n = 41, 56% f) underwent neuropsychological testing. The prevalence of impairment and classification ability of the TAP subtests were evaluated alongside standard paper-based tests, including the TMT and Montreal Cognitive Assessment, using receiver operating characteristic (ROC) analysis and regression. The TAP subtests identified significant impairments in sustained attention and processing speed in one-third of PCC patients, surpassing traditional tests in sensitivity, and classifying PCC with an AUC of 78%. Omissions in sustained attention significantly differentiated groups (OR = 1.14, p = 0.016, 95% CI [1.02-1.26]). Fatigue correlated with poorer performance on speed and accuracy (r > 0.30, p < 0.05). Cognitive slowing is prevalent in neurological PCC but is scarcely captured by conventional assessments. The TAP's computerized format with automated norming and independence from alphanumeric stimuli shows promise in improving the discriminatory ability for identifying attentional deficits in PCC patients.

摘要

新冠后神经综合征(PCC)常伴有注意力缺陷,影响日常功能。传统的纸质测试,如连线测验(TMT),由于其测试时间短且依赖数字和字母排序,可能无法充分捕捉这些损伤。本研究评估了计算机化注意力表现测试(TAP)的三个子测试作为检测PCC注意力损伤替代方法的有效性。在正在进行的NEURO LC - 19 DE研究中,108名年龄在18至79岁之间、有PCC相关认知主诉的受试者(n = 67,女性占73%)和健康对照者(n = 41,女性占56%)接受了神经心理学测试。使用受试者工作特征(ROC)分析和回归,将TAP子测试的损伤患病率和分类能力与包括TMT和蒙特利尔认知评估在内的标准纸质测试进行了比较评估。TAP子测试在三分之一的PCC患者中发现了持续注意力和处理速度方面的显著损伤,在敏感性方面超过了传统测试,分类PCC的曲线下面积(AUC)为78%。持续注意力方面的遗漏显著区分了不同组(比值比 = 1.14,p = 0.016,95%置信区间[1.02 - 1.26])。疲劳与速度和准确性方面较差的表现相关(r > 0.30,p < 0.05)。认知减慢在神经PCC中很普遍,但传统评估几乎无法捕捉到。TAP的计算机化形式具有自动标准化且不受字母数字刺激影响的特点,在提高识别PCC患者注意力缺陷的鉴别能力方面显示出前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8789/12234741/70a2d4feb437/41598_2025_9128_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8789/12234741/3174b54d983c/41598_2025_9128_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8789/12234741/78f64896ce76/41598_2025_9128_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8789/12234741/b885faf0e7ed/41598_2025_9128_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8789/12234741/82ea91319e09/41598_2025_9128_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8789/12234741/70a2d4feb437/41598_2025_9128_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8789/12234741/3174b54d983c/41598_2025_9128_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8789/12234741/78f64896ce76/41598_2025_9128_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8789/12234741/b885faf0e7ed/41598_2025_9128_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8789/12234741/82ea91319e09/41598_2025_9128_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8789/12234741/70a2d4feb437/41598_2025_9128_Fig5_HTML.jpg

相似文献

[1]
Validity of the test for attentional performance in neurological post-COVID condition.

Sci Rep. 2025-7-7

[2]
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Cochrane Database Syst Rev. 2022-5-20

[3]
Antibody tests for identification of current and past infection with SARS-CoV-2.

Cochrane Database Syst Rev. 2022-11-17

[4]
Turkish Version of the Video-Naming Test for Assessing Verb Anomia (DVAQ-30): Normative Data for the Adult Turkish Population and Validation Study in Mild Cognitive Impairment and Alzheimer's Disease.

Int J Lang Commun Disord. 2025

[5]
One-year practice effects predict long-term cognitive outcomes in Parkinson's disease.

J Parkinsons Dis. 2025-4-29

[6]
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.

Cochrane Database Syst Rev. 2024-10-14

[7]
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.

Cochrane Database Syst Rev. 2022-7-22

[8]
Occupational therapy for cognitive impairment in stroke patients.

Cochrane Database Syst Rev. 2022-3-29

[9]
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.

Cochrane Database Syst Rev. 2021-9-2

[10]
Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.

Cochrane Database Syst Rev. 2022-6-16

本文引用的文献

[1]
Assessment of psychosocial aspects in adults in post-COVID-19 condition: the EURONET-SOMA recommendations on core outcome domains for clinical and research use.

BMC Med. 2025-2-11

[2]
Diagnostic accuracy of the Montreal Cognitive Assessment in screening for cognitive impairment in initially hospitalized COVID-19 patients: Findings from the prospective multicenter NeNeSCo study.

J Int Neuropsychol Soc. 2025-1

[3]
Is There such a Thing as Post-Viral Depression?: Implications for Precision Medicine.

Biomol Ther (Seoul). 2024-11-1

[4]
Effects of cognitive training and group psychotherapy on cognitive performance of post COVID-19 patients: an exploratory and non-randomized clinical trial.

Eur Arch Psychiatry Clin Neurosci. 2024-12

[5]
Current Advances in Computerized Cognitive Assessment for Mild Cognitive Impairment and Dementia in Older Adults: A Systematic Review.

Dement Geriatr Cogn Disord. 2025

[6]
Long Neuro-COVID-19: Current Mechanistic Views and Therapeutic Perspectives.

Biomolecules. 2024-8-28

[7]
On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.

J Alzheimers Dis. 2024

[8]
Neural basis of fatigue in post-COVID syndrome and relationships with cognitive complaints and cognition.

Psychiatry Res. 2024-10

[9]
"Brain Fog" After COVID-19 Infection: How the Field of Neuropsychology Can Help Clear the Air.

Adv Exp Med Biol. 2024

[10]
Neurocognitive and Neuropsychiatric Sequelae in Long COVID-19 Infection.

Brain Sci. 2024-6-14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索